Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 5

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 5
---
 a transfer by way of continuation in a jurisdiction outside the Cayman Islands).
On any other matters submitted to a vote of our shareholders prior to or in connection with the completion of our initial business combination,
holders of our Class B ordinary shares and holders of our Class A ordinary shares will vote together as a single class, except
as required by law. Upon consummation of this offering or thereafter, we will repay up to $250,000 in loans made to us by our sponsor
to cover offering-related and organizational expenses, and we will begin paying our sponsor $10,000 per month for office space, utilities
and secretarial and administrative support. In the event that following this offering we obtain working capital loans from our sponsor
or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs related to our initial business
combination, up to $1,500,000 of such loans may be convertible into warrants of the post-business combination entity at a price of $1.00
per warrant at the option of the lender, which conversion may result in material dilution to our public shareholders. Additionally, our
initial shareholders, officers or directors, or our or their affiliates, will be entitled to reimbursement for any out-of-pocket expenses
related to identifying, investigating and completing an initial business combination. Each of our independent directors will also receive
for their services as directors an indirect interest in 30,000 founder shares through membership interests in DirectorCo. As a result,
there may be actual or potential material conflicts of interest between members of our management team, our initial shareholders, including
our sponsor, and our or their respective affiliates on the one hand, and purchasers in this offering on the other. See “ Summary — Initial Shareholders Information,” “Summary — The Offering — Founder Shares,” “ Summary — The Offering — Transfer Restrictions on Founder Shares,” “ Summary — The Offering — Founder Shares Conversion and Anti-Dilution Rights” and “ Risk Factors — Risks Relating to our Management Team — The nominal purchase price paid by our initial shareholders for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our initial shareholders are likely to make a substantial profit on their investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline” for further discussion on our initial shareholders’ and our affiliates’ securities and compensation.

As more fully discussed in “